Girentuximab Biosimilar - Research Grade,ichor.bio,ICH5013
Detects human Carbonic Anhydrase IX. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Girentuximabï؟½Biosimilar - Research Grade.
Host
CHO cells
Reactivity
Human
Platform ID
BAB386313774
ichor.bio
Contact
Tel:
Fax:
Email:
Product Specifications
Scientific Background
Synonyms
Specifications
NameGirentuximab Biosimilar - Research Grade
Cat. No.ICH5013
Accession NumberQ16790
HostCHO cells
IsotypeHuman IgG1
ReactivityHuman
Concentration5mg/ml
TargetCarbonic Anhydrase IX
Purity>95% by SDS-PAGE
Endotoxin Level≤ 1.0 EU/mg as determined by the LAL method
ShippingBlue ice
FormulationICH3002
StorageThis biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Regulatory StatusFor research use only
Scientific Background
RUO girentuximab binds to the extracellular proteoglycan (PG)-like domain, which is unique to CA IX compared to other isoforms and lies adjacent to the catalytic domain. In addition to therapy, girentuximab has also been utilized as an imaging agent.
Synonyms
CAIX, CA-IX
Category Paths
- Products>Primary Antibodies>Biosimilar Antibodies
Request a product
Please provide the required information below so that we can quickly source your products.